Focus on Lymphoma
In a phase III trial, people with early-stage, low-risk Hodgkin lymphoma who received lower doses of chemotherapy and/or radiotherapy had clinical outcomes that were no worse than those of people who received higher doses.
Lower-Dose Treatments for Early-Stage Hodgkin Lymphoma Do Not Compromise Results
In a phase III trial, people with early-stage, low-risk Hodgkin lymphoma who received lower doses of chemotherapy and/or radiotherapy had clinical outcomes that were no worse than those of people who received higher doses.
Emerging Therapies in Non-Hodgkin Lymphoma
Research into the causes, prevention, and treatment of non-Hodgkin lymphoma is being done in many medical centers throughout the world.
What Happens After Treatment for Non-Hodgkin Lymphoma?
Completing treatment can be both stressful and exciting. You will be relieved to finish treatment, yet it is hard not to worry about cancer coming back. This is a very common concern among those who have had cancer.
